Found 387 matches for
Today University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials of a vaccine against SARS-CoV-2 across two different dose regimens, resulting in an average efficacy of 70.4%.
Artificial Intelligence (AI) Events Research
Professor Newton Howard of NDS is Chair and Founder of the Howard Brain Sciences Foundation (HBSF). Here he writes about HBSF's first annual Brain Matter(s) Event in which Tipu Aziz, NDS Professor of Neurosurgery, was one of the keynote speakers.